Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SCFD2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SCFD2 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SCFD2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Scfd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SCFD2 mRNA | CTD | PMID:24680724 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCFD2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCFD2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | SCFD2 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of SCFD2 gene | CTD | PMID:31601247 | 7,12-dimethyltetraphene | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | acetylsalicylic acid | increases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Aspirin results in increased expression of SCFD2 mRNA | CTD | PMID:11906190 | aflatoxin B1 | affects expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SCFD2 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | SCFD2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SCFD2 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of SCFD2 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SCFD2 mRNA | CTD | PMID:21632981 more ... | aristolochic acid A | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SCFD2 mRNA | CTD | PMID:33212167 | atrazine | increases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Atrazine results in increased expression of SCFD2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the expression of SCFD2 mRNA | CTD | PMID:25690898 | benzo[a]pyrene | affects methylation | ISO | SCFD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SCFD2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SCFD2 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SCFD2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SCFD2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases methylation | ISO | SCFD2 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of SCFD2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SCFD2 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Scfd2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SCFD2 mRNA | CTD | PMID:33221593 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SCFD2 gene | CTD | PMID:28505145 | carbamazepine | affects expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SCFD2 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Scfd2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of SCFD2 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SCFD2 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Scfd2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SCFD2 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Scfd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCFD2 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SCFD2 mRNA | CTD | PMID:19561079 more ... | cisplatin | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SCFD2 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SCFD2 mRNA | CTD | PMID:19320972 | copper atom | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SCFD2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SCFD2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SCFD2 mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCFD2 mRNA | CTD | PMID:28628672 | dioxygen | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of SCFD2 mRNA | CTD | PMID:26516004 | dorsomorphin | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SCFD2 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SCFD2 mRNA | CTD | PMID:35436446 | ethyl methanesulfonate | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SCFD2 mRNA | CTD | PMID:23649840 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of SCFD2 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Scfd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCFD2 mRNA | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of SCFD2 mRNA | CTD | PMID:23649840 and PMID:27664576 | fulvestrant | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SCFD2 gene | CTD | PMID:31601247 | genistein | decreases expression | ISO | Scfd2 (Mus musculus) | 6480464 | Genistein results in decreased expression of SCFD2 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SCFD2 mRNA | CTD | PMID:33387578 | glyphosate | increases methylation | EXP | | 6480464 | Glyphosate results in increased methylation of SCFD2 gene | CTD | PMID:31011160 | hydroquinone | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of SCFD2 mRNA | CTD | PMID:31256213 | indometacin | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCFD2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SCFD2 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Scfd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCFD2 mRNA | CTD | PMID:20938992 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SCFD2 gene | CTD | PMID:35440735 | methyl methanesulfonate | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of SCFD2 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SCFD2 mRNA | CTD | PMID:28001369 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of SCFD2 gene | CTD | PMID:33148267 | N-nitrosomorpholine | decreases expression | EXP | | 6480464 | N-nitrosomorpholine results in decreased expression of SCFD2 mRNA | CTD | PMID:19716841 | O-methyleugenol | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of SCFD2 mRNA | CTD | PMID:32234424 | paracetamol | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SCFD2 mRNA | CTD | PMID:21420995 and PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SCFD2 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | Scfd2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SCFD2 mRNA | CTD | PMID:17562736 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of SCFD2 gene | CTD | PMID:33148267 | pinostrobin | increases phosphorylation | ISO | SCFD2 (Homo sapiens) | 6480464 | pinostrobin results in increased phosphorylation of SCFD2 protein | CTD | PMID:37164308 | potassium chromate | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SCFD2 mRNA | CTD | PMID:22714537 | quercetin | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SCFD2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SCFD2 mRNA | CTD | PMID:28595984 | sodium arsenite | affects expression | ISO | SCFD2 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of SCFD2 mRNA | CTD | PMID:34032870 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SCFD2 mRNA | CTD | PMID:23411599 and PMID:34492290 | trichostatin A | increases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SCFD2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCFD2 mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | Scfd2 (Mus musculus) | 6480464 | triptonide results in increased expression of SCFD2 mRNA | CTD | PMID:33045310 | valproic acid | decreases methylation | ISO | SCFD2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SCFD2 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | SCFD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCFD2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SCFD2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SCFD2 mRNA | CTD | PMID:25979313 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of SCFD2 gene | CTD | PMID:31682807 | zinc atom | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Zinc results in decreased expression of SCFD2 mRNA | CTD | PMID:19071009 | zinc(0) | decreases expression | ISO | SCFD2 (Homo sapiens) | 6480464 | Zinc results in decreased expression of SCFD2 mRNA | CTD | PMID:19071009 | |